Session » Abstracts: Sjögren's Syndrome – Basic & Clinical Science (0984–0987)

Date: Sunday, November 7, 2021

Time: 3:30PM-4:30PM

Meeting: ACR Convergence 2021

3:30PM-3:45PM: Abstract Number: 0984

Human Papillomavirus Infection Increases Risk of Primary Sjogren’s Syndrome: A Population-based Cohort Study over a 15-year Follow-up

3:45PM-4:00PM: Abstract Number: 0985

Sjӧgren’s Symptom Burden Drives Immunomodulatory Therapies but Correlates Poorly with Disease Severity Markers

4:00PM-4:15PM: Abstract Number: 0986

Ianalumab (VAY736) Safety and Efficacy in Patients with Sjögren’s Syndrome: 52 Week Results from a Randomized, Placebo-controlled, Phase 2b Dose-ranging Trial

4:15PM-4:30PM: Abstract Number: 0987

Rituximab Prevents the Progression of B-cell Driven Inflammatory Infiltrate in the Minor Salivary Glands of Primary Sjogren’s Syndrome by Downregulating Immunological Pathways Key in Ectopic Germinal Centre Organization: Results from the TRACTISS Trial

« View all sessions from this meeting